Blog
← All articles

NAV Financing Explained: How PE Borrows Against Its Own Portfolio to Pay Distributions

9 min read

Key takeaways
  • A NAV loan is debt secured against an entire fund portfolio rather than a single company — one facility, cross-collateralised across every holding, sized to the net asset value of the fund
  • The market is roughly $100 billion of facilities outstanding as of late 2024, with lenders projecting a $600–700 billion addressable opportunity by 2030 — small against private equity's scale, growing fast off a frozen exit market
  • The same loan is used two opposite ways: offensively to fund add-ons and follow-ons (defensible), and defensively to manufacture distributions and lift DPI ahead of a fundraise (the controversy)
  • The defensive use does not create value — it pulls liquidity forward at SOFR plus a spread and stacks fund-level leverage on top of company-level LBO debt. In July 2024 ILPA published guidance demanding LPAC consent and disclosure after an LP revolt

A $100 Billion Market Solving the Same Problem Secondaries Do

Private equity spent 2023 and 2024 unable to sell its companies. The M&A and IPO windows narrowed, distributions to investors fell to roughly 11% of fund NAV — the lowest in over a decade — and LPs who were promised cash got paper marks instead. The secondary market was one release valve. NAV financing is the other.

A NAV facility lets a fund borrow against the value of the companies it already owns. Estimates put outstanding facilities near $100 billion as of late 2024, and lenders such as 17Capital — now owned by Oaktree — model an addressable market of $600–700 billion by 2030. Treat the 2030 figures as vendor projections, not fact, but the direction is not in doubt: Rede Partners' 2025 survey found the average volume per lender jumped 142% in a single year, from €330 million in 2023 to over €800 million in 2024.

Most candidates can describe a leveraged buyout — debt against one company — without knowing that funds now lever the whole portfolio a second time. That gap is the opportunity, and the mechanics matter because the structure is the controversy.

What a NAV Loan Actually Is: One Loan Against the Whole Portfolio

The defining feature is the collateral. An LBO loan is secured against a single company's cash flows and assets. A NAV loan is secured against the net asset value of an entire fund — a diversified pool of portfolio companies — and repaid from the distributions those companies eventually throw off. It sits at the fund level, above every individual deal.

Students routinely confuse it with the other fund-level facility, the subscription line. They are opposite tools secured against opposite things.

Subscription (Capital Call) LineNAV Facility
Secured against LPs' undrawn commitments — money not yet calledSecured against the NAV of companies already owned — money already deployed
Used early in fund life, as a bridge before capital callsUsed mid-to-late life, once the fund is largely invested
Short-term, low-risk, repaid by calling capital from LPsMulti-year, repaid by portfolio distributions or refinanced
Lifts reported IRR by delaying the capital-call clockLifts DPI by creating distributions before exits arrive

Offence vs Defence: The Same Loan, Two Opposite Purposes

NAV financing is not inherently good or bad. The argument turns entirely on what the borrowed money is used for, and there are two cases.

The offensive case — accretive. The fund draws on the facility to fund bolt-on acquisitions for a strong portfolio company, inject growth capital into a winner, or back a follow-on it could not otherwise finance because the fund is fully invested. Here the loan funds value creation: it buys assets or equity that should compound above the cost of the debt. This is the use lenders point to, and it is genuinely defensible.
The defensive case — distributive. The fund draws on the facility to send cash to LPs — to manufacture a distribution the exit market will not provide. No asset is bought, no company is improved. Capital is simply pulled forward and handed back, secured against the portfolio the LPs already own. This is the use that triggered the backlash.
5–25% Typical loan-to-value on a PE NAV facility, capped near 30% — deliberately conservative against a portfolio that may already carry 4–6x leverage at the company level. The LTV discipline is real; the leverage-on-leverage is the catch

The conservative LTV is the lenders' best argument: at 5–25% of NAV, a facility has a thick equity cushion beneath it. But the cushion sits on top of the leverage already inside each portfolio company. A fund borrowing 20% against a portfolio of businesses that are themselves levered 5x is not running a 20%-levered book.

Why a debt-funded distribution flatters the numbers DPI — distributions to paid-in capital — measures the cash a fund has actually returned, and it has become the metric LPs watch when deciding whether to commit to the next fund. A NAV loan lets a GP raise DPI without selling anything: borrow against the portfolio, distribute the proceeds, and the ratio climbs. Pulling cash forward also flatters IRR, which rewards early returns. A GP fundraising into a weak market can therefore present a healthier-looking track record than its realised exits justify — which is precisely the concern LPs raised.

The sleight of hand is that a debt-funded distribution is not a return of profit — it is a loan the LPs ultimately repay, with interest, out of their own portfolio's future proceeds. The headline DPI rises today; the cash available at the end falls by the cost of the borrowing.


The Bull and Bear: Cross-Collateralisation, Leverage on Leverage, and an Untested Tool

A serious candidate argues both sides before naming a view. The bull case is real: at conservative LTVs, NAV finance is a flexible, relatively cheap way to fund accretive add-ons or smooth the J-curve, and a diversified portfolio is genuinely safer collateral than any single company. Used offensively, it is a legitimate capital-efficiency tool.

The bear case lives in the structure. Because the facility is secured against the whole fund, it is cross-collateralised: the strong companies are pledged to support a loan whose proceeds may have rescued — or been distributed away from — the weak ones. A winner that should have returned clean proceeds to LPs can instead see its exit cash swept first to repay the facility. The risk in one corner of the portfolio is socialised across all of it.

Leverage on leverage Every company in a buyout portfolio already carries its own acquisition debt — often 4–6x EBITDA. A NAV loan adds a second layer of borrowing at the fund level, on top of all of it. In a benign market the two layers are independent; in a downturn they compound. Falling portfolio valuations shrink the NAV the facility is sized against, which can trip an LTV covenant and force a cash sweep or repayment at exactly the moment the underlying companies are also under pressure from their own lenders. The tool has not yet been tested through a deep, prolonged downturn at scale.

The clearest tell is the cash sweep. Most PE NAV facilities divert distributions to repay the loan first, sometimes throughout the facility's life, sometimes only once a covenant LTV is breached. That feature is benign while the portfolio performs and punishing when it does not — it converts a downturn into a liquidity drain precisely when LPs were counting on cash.

The LP Revolt: ILPA Wrote Rules Because GPs Were Not Asking

The controversy became formal in 2024. LPs reported three specific grievances: they often had no insight into when a NAV facility was even in place, older limited partnership agreements contained no language governing fund-level borrowing, and GPs were drawing facilities without notifying the LP advisory committee at all.

On 25 July 2024, ILPA — the body that represents institutional investors — published its NAV-Based Facilities Guidance. The core demands are governance rather than prohibition: seek LPAC consent before drawing a facility unless the LPA explicitly permits it, and disclose the rationale, size, structure, key economic terms, and conflicts of interest. The guidance does not ban NAV loans. It insists the people whose assets secure them get to see — and sign off on — the trade.

Interview framing If asked about NAV financing, do not stop at "borrowing against the portfolio." Make the distinction that signals you understand incentives: the same facility is accretive when it funds add-ons and corrosive when it funds distributions to flatter DPI before a fundraise. Then name the structural risks — cross-collateralisation and leverage stacked on leverage — and close with the 2024 ILPA guidance as the market's governance response. That is a buy-sider's answer, not a textbook one.

Value Creation or Borrowed Time?

The honest verdict holds both cases in sequence. As a permanent capital-efficiency tool — funding accretive growth at conservative LTVs against diversified collateral — NAV finance is legitimate infrastructure that mature funds will keep using when exits reopen. As a pressure valve for the 2023–25 DPI drought, a meaningful share of recent volume was funds borrowing to manufacture distributions they could not earn, which creates no value and quietly mortgages the portfolio LPs already own.

The thing to watch is not the headline market size but the use of proceeds. A facility funding a bolt-on that compounds above its cost of debt is alignment. A facility funding a distribution timed to a fundraise is a GP buying a better-looking track record on the LPs' own credit. The ILPA guidance exists to force that distinction into the open, because the structure alone will not reveal it.

Careers: A Lender's Skillset Pointed at Funds, Not Companies

NAV financing sits inside the fund finance market — a specialist corner spanning the banks that have long run subscription lines and the dedicated funds, such as 17Capital, Pemberton, and the fund-finance arms of the large credit platforms, that underwrite NAV facilities. The work is credit underwriting, but the borrower is a fund, not a business. You are not building a three-statement model on one company; you are stress-testing a portfolio's NAV trajectory, distribution pacing, and the LTV cushion under a downturn — closer to a credit or secondaries seat than to coverage banking.

The skill that compounds in fund finance is not the modelling — that is a commodity any sharp analyst learns. It is judgement on the durability of other people's marks: deciding how far a GP's carrying values would fall in a real downturn, and therefore how much the portfolio can safely bear. The lenders who win price that risk correctly and reach the strongest sponsors first, and the people who own those sponsor relationships are the ones who get paid. The toolkit gets you in the door; the career is built on judgement and origination.

The natural feeders are leveraged finance, private credit, fund-focused advisory, and PE itself — anywhere you have learned to read leverage from the lender's side. It is one of the faster-growing parts of the buy-side, expanding while traditional buyout hiring has flattened.

Take Your Preparation Further

To speak credibly about where this capital sits, map the fund-finance lenders the way you would map banks: use our free Firm Research Tracker to follow the major NAV and fund-finance platforms. For the full set of PE interview questions and model answers — including fund structure and value-creation topics — see the PE Interview Masterclass.

For the metrics this entire story turns on, see PE Fund Performance Metrics — DPI, IRR, and why GPs care so much about both. For the other half of the liquidity stack built during the same drought, see PE Secondaries Explained, and for the debt that sits inside each portfolio company, Private Credit Explained.

Ready for personalised feedback? Book a 1-on-1 mentoring session with an experienced IB/PE professional.

Ready for personalised feedback on your preparation?